New Product Announcement
RBC Bioscience is Bringing its Lab Automation Solutions to the American Research and Diagnostics Market
Rutgers Scientists Develop Test That Easily Detects Variants Causing COVID-19
Rutgers scientists have developed a lab test that can quickly and easily identify which variant of the virus causing COVID-19 has infected a person, an advance expected to greatly assist health officials tracking the disease and physicians treating infected patients.
Study reveals source of DNA mutations in melanoma
GRAND RAPIDS, Mich. (JULY 30, 2021) — The mutations that give rise to melanoma result from a chemical conversion in DNA fueled by sunlight — not just a DNA copying error as previously believed, reports a study by Van Andel Institute scientists published today in Science Advances.
A year of COVID-19: Researchers pivot to answer questions raised by the pandemic
When news started circulating early last year about a virus in China that was spreading like wildfire, faculty researchers found themselves evaluating their projects and wondering how they could contribute their skills and knowledge to this global problem.
Promising COVID-19 Rapid Test Technology Enters Phase 1 of NIH Challenge
A promising new COVID-19 rapid-testing technology platform developed by Rover Diagnostics and Columbia Engineering has been selected by the NIH to enter Phase 1 of the RADx initiative to support new COVID-19 testing technologies. The affordable, portable, and ultrafast point-of-care Rover platform provides reverse transcription polymerase chain reaction results in eight minutes, faster than any other test of its kind, with targeted accuracy to match laboratory-based tests.
Coronavirus Testing Begins at the Weizmann Institute of Science
On April 12, the Weizmann Institute began using its cutting-edge PCR facilities to perform coronavirus testing after an agreement was reached with Israel’s Ministry of Health.